 |
live bacterial product consisting of defined consortia of Clostridium clusters live bacterial product consisting of defined consortia of Clostridium clusters |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of recurrent Clostridium difficile infection in individuals with prior recurrent Clostridium difficile infection |
| USA Market Approval | USA |
| USA Designation Date | 2017-11-02 00:00:00 |
| Sponsor | Vedanta Biosciences, Inc.;19 Blackstone Street, Third Floor;Cambridge, Massachusetts, 02139 |
